Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

Overview of attention for article published in Journal of Hematology & Oncology, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 48 X posts from 35 X users, with an upper bound of 62,659 followers.

RT @md_addison: Hypertension development after the initiation of next generation BTK inhibitor: https://t.co/TObgC0zM6K Acalabrutinib: >8…

RT @avirupguha: Excellent study by the best team studying BTKi toxicity! HTN a class effect not AF. Interesting and makes me wonder about r…

Daily word art by Kesho and article by Chen et al. at: https://t.co/8Eqzwnfnns https://t.co/z9XJKGCOtD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 44 additional X posts.